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MGA and Growth Promotants Administered  
to Beef Feedlot Heifers Have No Effect  
on Subsequent Oocyte Quality or in vitro 
Embryo Production
N. Miller, D. Grieger, and K. Fike 
Introduction
Beef feedlot heifers have the potential to serve as viable donors of oocytes post-slaughter 
for in vitro embryo production. Oocyte quality is a critical factor affecting the success of 
in vitro embryo production and can be influenced by factors such as age and reproduc-
tive status, ovarian follicle size, and nutritional status of the donor female. In a conven-
tional feedlot setting, heifers are typically administered steroid-based growth promo-
tants and fed melengestrol acetate (MGA) for suppression of estrus, which increases 
circulating concentrations of reproductive steroids, particularly estradiol. The effects of 
these management practices on oocyte quality and numbers are unknown. The purpose 
of this study was to compare oocytes harvested from traditionally managed beef feedlot 
heifers implanted with growth promotants and fed MGA with oocytes from heifers 
given neither MGA nor growth promotants, and to evaluate potential effects of these 
feedlot management practices on early embryo development.
Experimental Procedures
Beef heifers (n = 172) were fed a finishing diet at the Kansas State University Beef 
Research Center feedlot for 120 days. Heifers were divided into 2 treatments:  
(1) conventionally managed heifers (MGA-Implant) were fed MGA (0.5 mg/head/day) 
for 120 days and implanted with a single growth promotant 120 days prior to harvest 
(Revalor IH; 80 mg trenbolone acetate and 8 mg estradiol; Merck Animal Health, 
Summit, NJ); and (2) control heifers did not receive either MGA or growth promo-
tants during the finishing period. 
Heifers were harvested and ovaries were collected within 30 minutes of harvest, then 
grouped within treatment based on time from harvest to ovary collection. Oocytes were 
aspirated from collected ovaries using a vacuum pump system and maintained in groups 
based on time of heifer harvest. All media were provided by Sexing Technologies, 
Inc. (Navasota, TX). Oocytes were washed twice in TL-Hepes media then evaluated. 
Oocytes that were denuded, had discolored cytoplasm, or were starting to degener-
ate were recorded and subsequently removed from the study. Remaining oocytes were 
placed in M199 holding media until all oocytes were collected. Four to five hours post-
slaughter, all oocytes were placed in maturation media and shipped overnight to begin 
the in vitro fertilization (IVF) process at Sexing Technologies, Inc. laboratory facilities. 
After 23.5 hours in maturation media, oocytes were placed in fertilization media with 
semen from a Holstein bull with proven IVF quality (per Sexing Technologies, Inc.) 
at 1.0 x 106 sperm/mL. After 18 hours in fertilization media, the presumptive zygotes 
were washed twice in TL-Hepes media. All cumulus cells were then removed from the 
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zygotes. Any zygotes with cracked zona pellucidas, shrinking cytoplasms, or lacking 
clear polar bodies were recorded and subsequently removed from the study. Remaining 
zygotes were placed in culture media for 7 days. 
On day 2 post-IVF, developmental stages were assessed, including the number that 
achieved 8-cell, 2- to 4-cell, and 1-cell stages of early embryo development. Any cells 
that had not divided by day 2 were removed from the study. On day 7, embryo grades 
were assigned. Morula, early blastocyst, and blastocyst stages of development were 
classified as C2 embryos but considered to be of insufficient quality for freezing; C1− 
embryos were those that were blastocyst or expanded blastocyst stages and freezable; 
and C1 embryos were those with a very compact inner cell mass and were beginning to 
hatch and were freezable. 
Results and Discussion
A total of 1,820 oocytes were harvested from 152 ovaries in the MGA-Implant group. 
The control group yielded 1,272 oocytes from 145 ovaries. A tendency for a time × 
treatment interaction was observed for the number of oocytes per ovary (P = 0.07). 
Fertilization rate (zygotes produced per the number of oocytes with opportunity to be 
fertilized) was similar for both treatments (MGA-Implant: 79.9%, Control: 82.3%; 
Figure 1), indicating no effect of treatment on the ability of oocytes to be fertilized. A 
similar percentage of zygotes (successfully fertilized oocytes) per ovary cleaved by day 2 
post-IVF (MGA-Implant: 46.8%, Control: 47.9%; Figure 1). Cleavage rates were deter-
mined by evaluating the total number of zygotes that had achieved the 2- to 8-cell stage 
of early embryo development by day 2 post-IVF per number of zygotes produced and 
are indicative of early embryonic growth. A similar number of embryos per ovary were 
produced for both the MGA-Implant and control groups (Figure 2). Freezable embryos 
(C1 and C1−) produced were also similar for both treatments (Figure 2). Across both 
groups, the majority of embryos produced were assigned a grade of C2, which are those 
embryos that are of sufficient quality for fresh transfer, but not freezable. 
Beef feedlot heifers fed MGA and administered steroid-based growth promotants can 
serve as a viable source of oocytes for in vitro embryo production. Feeding MGA and 
administering growth promotants to heifers does not affect oocyte fertilization rate, 
early embryo development, or number of in vitro embryos produced compared with 
heifers not fed MGA or administered growth promotants. 
Implications
Administration of MGA and growth promotants to feedlot heifers has no subsequent 
effects on number of oocytes harvested or in vitro embryos produced. Beef feedlot heif-



































Figure 1. Fertilization (zygotes produced per oocytes with opportunity to be fertilized) 
and cleavage rates (2- to 8-cell embryos produced per number of zygotes) of oocytes and 
zygotes, respectively. Oocytes were harvested from beef feedlot heifers fed melengestrol 
acetate (MGA) and implanted with growth promotants (MGA-Implant) or untreated 



























Figure 2. Total and freezable embryos produced per ovary from in vitro fertilization of 
oocytes harvested from beef feedlot heifers fed melengestrol acetate (MGA) and implanted 
with growth promotants (MGA-Implant) or untreated (Control).
